Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jumei Shi

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Clinical and Experimental Medicine|November 10, 2015
Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Guang Yang, Ying Han, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Lu Gao, Guang Yang, et al.
Cancer Research|April 10, 2015
Decreased ferroportin promotes myeloma cell growth and osteoclast differentiationZhimin Gu, He Wang, Jiliang Xia, et al.
Acta Biochimica Et Biophysica Sinica|September 12, 2015
Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivoGuang Yang, Qianqiao Zhang, Yuanyuan Kong, et al.
Biochemical and Biophysical Research Communications|October 29, 2011
Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class IXiaosong Wu, Yang Shao, Yi Tao, et al.
Oncotarget|March 5, 2016
Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3Houcai Wang, Bingqian Xie, Yuanyuan Kong, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2016
Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Yuanyuan Kong, Houcai Wang, et al.
American Journal of Hematology|November 4, 2024
Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in ChinaJing Luo, Jiaojiao Zhang, Ligen Liu, et al.
Biomed Research International|May 23, 2015
Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2Lu Gao, Minjie Gao, Guang Yang, et al.
Acta Biochimica Et Biophysica Sinica|April 23, 2021
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cellsRuye Ma, Dandan Yu, Yu Peng, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Clinical and Experimental Medicine|November 10, 2015
Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Guang Yang, Ying Han, et al.
International Journal of Clinical and Experimental Pathology|July 18, 2014
Lenalidomide after stem-cell transplantation for multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Lu Gao, Guang Yang, et al.
Cancer Research|April 10, 2015
Decreased ferroportin promotes myeloma cell growth and osteoclast differentiationZhimin Gu, He Wang, Jiliang Xia, et al.
Acta Biochimica Et Biophysica Sinica|September 12, 2015
Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivoGuang Yang, Qianqiao Zhang, Yuanyuan Kong, et al.
Biochemical and Biophysical Research Communications|October 29, 2011
Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class IXiaosong Wu, Yang Shao, Yi Tao, et al.
Oncotarget|March 5, 2016
Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3Houcai Wang, Bingqian Xie, Yuanyuan Kong, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2016
Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trialsMinjie Gao, Yuanyuan Kong, Houcai Wang, et al.
American Journal of Hematology|November 4, 2024
Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in ChinaJing Luo, Jiaojiao Zhang, Ligen Liu, et al.
Biomed Research International|May 23, 2015
Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2Lu Gao, Minjie Gao, Guang Yang, et al.
Acta Biochimica Et Biophysica Sinica|April 23, 2021
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cellsRuye Ma, Dandan Yu, Yu Peng, et al.
Pageof 9